Data / Form D filings / AQUINOX PHARMACEUTICALS (USA) INC
AQUINOX PHARMACEUTICALS (USA) INC: Form D filings
AQUINOX PHARMACEUTICALS (USA) INC, a company in Richmond, British Columbia, Canada, filed 5 Form D notices with the SEC between 2010 and 2013. The latest, on April 1, 2013, reports $14 million sold of a $21 million offering to 7 investors.
Find out what AQUINOX PHARMACEUTICALS (USA) INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5600 PARKWOOD WAY, SUITE 430, Richmond, British Columbia, Canada, V6V 2
- Phone
- (604) 629-9223
- Industry
- Other
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1404644
The full lists. Form D filings in other industries: 9,873 rows, $178.73, or the new rows each week for $19.10 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2013 | New notice | $20,999,962 | $13,999,975 | $6,999,987 | 7 | Mar 19, 2013 | sec.gov |
| Sep 26, 2011 | New notice | $3,536,035 | $3,536,035 | $0 | 6 | Sep 21, 2011 | sec.gov |
| Feb 11, 2011 | New notice | $4,724,298 | $4,724,298 | $0 | 6 | Jan 31, 2011 | sec.gov |
| Jun 25, 2010 | New notice | $3,531,483 | $3,531,483 | $0 | 1 | Jun 14, 2010 | sec.gov |
| Apr 15, 2010 | New notice | $6,227,549 | $4,827,549 | $1,400,000 | 5 | Mar 31, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kamran Alam | Executive Officer | |
| Elaine Jones | Director | |
| Daniel Levitt | Director | |
| Kenneth Galbraith | Director | |
| Asish Xavier | Director | |
| David Main | Executive Officer, Director |
Every Form D from the week of Apr 1, 2013 · All recent Other filings
Read from SEC EDGAR. Amount sold is what AQUINOX PHARMACEUTICALS (USA) INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.